All articles tagged with #zimmer biomet
Zimmer Biomet is acquiring Monogram Technologies for approximately $177 million to expand its orthopedic robotics portfolio, including autonomous surgical solutions, with the goal of becoming a leader in autonomous orthopedic surgery and enhancing its global offerings. The deal is expected to be neutral to earnings in 2025-2027 and accretive thereafter, supporting revenue growth from 2027.
Zimmer Biomet has announced a restructuring plan to enhance operational excellence, commercial focus, and collaboration, which includes reallocating investments and resources to drive long-term growth. As part of this plan, the company will reduce its global team by approximately three percent, affecting over 18,000 positions. Zimmer Biomet aims to simplify its processes and structure while remaining confident in its ability to execute its mission of alleviating pain and improving the quality of life for people worldwide.
3M has appointed Bryan Hanson, the CEO of Zimmer Biomet, to lead its upcoming health care spinoff. The spinoff, which is expected to be completed in 2022, will focus on providing innovative solutions for the health care industry. Hanson's experience in the medical device sector makes him a suitable candidate for leading the new venture.
Jim Cramer recommends buying Zimmer Biomet (ZBH) and believes it is a good investment. However, he does not share the same enthusiasm for Vital Energy and suggests investing in Pioneer (PXD) instead. Cramer is a believer in HighPeak Energy despite negative sentiment from short-sellers and hedge funds. He advises selling Activision Blizzard and investing in the undervalued Take-Two Interactive.